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Objective: To ﬁnd additional factors suggestive of hepatitis C virus (HCV) infection in
the general population by using data from a hepatitis virus survey.
Methods: This study collected data of HCV infection from a hepatitis virus survey.
The survey was conducted in 13 provinces in the northeast Thailand in 2014 and
2015. During the survey, a blood test was performed to screen for HCV. A ques-
tionnaire was also distributed to all participants asking about baseline characteristics,
risk factors for HCV infection, and daily life activities. Risk factors for HCV infection
were executed.
Results: There were 2112 participants for the survey. Of those, 110 participants
(5.21%) tested positive for HCV infection. After adjustment by multivariate logistic
regression, three factors were signiﬁcantly associated with HCV infection, namely
male gender, age, and family history of liver cancer. The adjusted ORs and 95% CI of
these factors were 3.14 (1.50, 6.56), 3.78 (1.12, 12.76), and 2.28 (1.08, 4.80),
respectively.
Conclusions: Male gender, increasing age, and family history of liver cancer are
predictors of HCV infection in endemic areas. Males with a family history of liver
cancer in their ﬁrst-degree relatives should be tested for HCV infection regardless of
symptoms.1. Introduction
Chronic hepatitis C virus (HCV) is an emerging infection
worldwide. The HCV infection rate increased globally from
2.3% in 1990 to 2.8% in 2005 [1]. In that year, there were an
estimated of 185 million people suffering from HCV infection,which may cause more than 350000 deaths annually [1,2]. The
HCV prevalence rate varies among countries. It is more
prevalent in developing countries such as those in East Asia or
Southeast Asia. Similar to HBV, HCV is a cause of both
cirrhosis and hepatocellular carcinoma. Approximately one-
fourth of cirrhosis or hepatocellular carcinoma cases are
caused by HCV [2]. In Japan, HCV was highly associated with
hepatocellular carcinoma at 90% [2].
Unlike HBV infection, there is no effective vaccine against
HCV and most people infected with HCV develop chronic
HCV infections (80%) [3]. HCV seems to be more problematic
for public health than HBV. Additionally, people infected with
chronic HCV may remain asymptomatic for years before
development of cirrhosis and hepatocellular carcinoma [4].
People may not be aware of this kind of HCV infection,
particularly in developing countries where people are not well
informed about health matters. HCV is mainly transmitted to
humans via blood components. In Thailand, the main risk
factors for HCV infection among blood donors are
intravenous drug use or history of blood transfusion [5]. Thiscle under the CC BY-NC-ND license (http://
Table 1
Baseline characteristics of subjects with and without HCV infection.
Factors Non-HCV
(n = 2002)
HCV
(n = 110)
P value
Gender <0.001
Female 1344 (67.13) 40 (36.36)
Male 658 (32.87) 70 (63.64)
Mean age (years) 48.13 (14.59) 50.64 (9.65) <0.001
Body mass index (kg/m2) 0.278
<29 160 (8.27) 12 (11.21)
>29 1774 (91.73) 95 (88.79)
Family history of liver cancer 0.032
No 1526 (87.25) 69 (79.31)
Yes 223 (12.75) 18 (20.69)
History of HBV vaccination 0.761
No 1589 (86.12) 82 (87.23)
Yes 256 (13.28) 12 (12.77)
Alcohol consumption 0.023
Never 1082 (63.80) 33 (50.00)
Currently/used to 614 (36.20) 33 (50.00)
Smoking history <0.001
Never 1529 (83.46) 60 (60.61)
Currently/used to 303 (16.54) 39 (39.39)
Supplements/herb use 0.034
No 1118 (63.92) 66 (75.00)
Yes 631 (36.08) 22 (25.00)
Exercise 0.589
No 1110 (63.54) 48 (66.67)
Yes 637 (36.46) 24 (33.33)
Table 2
Univariate and multivariate logistic regression analysis of factors asso-
ciated with HCV infection.
Factors Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Male gender 3.57 (2.39, 5.32) 3.14 (1.50, 6.56)
Age (year) 6.05 (2.21, 16.53) 3.78 (1.12, 12.76)
Family history of liver
cancer
1.78 (1.04, 3.05) 2.28 (1.08, 4.80)
Body mass index (kg/m2) 0.71 (0.38, 1.32) 0.50 (0.16, 1.55)
Supplement/herb use 0.59 (0.36, 0.96) 0.59 (0.30, 1.17)
Smoking history 3.28 (2.15, 4.99) 2.03 (0.99, 4.13)
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infection in the general population by using data from a
hepatitis virus survey. Early detection and treatment may
reduce risk of cirrhosis and hepatocellular carcinoma.
Additionally, these data may apply to populations in other
Asian countries.
2. Materials and methods
This study collected data of HCV infection from a hepatitis
virus survey. The survey was conducted in 13 provinces in the
northeastern Thailand in 2014 and 2015. Each survey was
announced via local media such as radio or advertisement.
Persons who registered in advance and participated in the pro-
gram were enrolled in the study. During the survey, a blood test
was performed to screen for HCV. A questionnaire was also
distributed to all participants asking about baseline characteris-
tics, risk factors for HCV infection, and daily life activities.
Details of the questionnaire were as follows. Participants
were asked about family history of liver cancer, history of HBV
vaccination over their lifetimes, alcohol consumption, smoking
habits, herb/supplement use, and exercise habits. Family history
of liver cancer was deﬁned by the history of liver cancer in
ﬁrst-degree relatives. History of HBV vaccination in their
lifetime was asked. Alcohol consumption was categorized as 1)
never 2) used to or currently consumed. Similarly, smoking
history was deﬁned as current/previous smoker vs. non-smoker.
History of current supplements/herb use was asked. Exercise
activities were categorized as whether or not the participant
engaged in regular exercise for more than 30 min/d three times
a week.
Participants were divided into two groups according to the
HCV test, anti-HCV positive and negative. Data were compared
between the groups using descriptive statistics. Univariate lo-
gistic regression analysis was applied to calculate the crude odds
ratios (ORs) of individual variables for HCV infection. All
variables were included in subsequent multivariate logistic
regression analyses. A backward stepwise method was used to
determine the ﬁnal model. Factors with P value of more than
0.25 were excluded. Analytical results were presented as
adjusted ORs, and 95% conﬁdence intervals (CIs). All analyses
were performed using STATA software (College station, Texas,
USA).
3. Results
There were 2112 participants for the survey. Of those, 110
participants (5.21%) tested positive for HCV infection. There
were six signiﬁcant factors between those with and without
HCV infection including age, sex, family history of liver cancer,
alcohol consumption, history of smoking, and history supple-
ment/herb use (Table 1). Those with HCV infection had
signiﬁcantly higher mean age (50 vs. 48 years; P < 0.001) and
lower proportion of supplement/herb use (25% vs. 36%;
P = 0.034) than those without HCV infection. The HCV
infection group had higher proportions than the non-HCV
infection group in other categories. For example, the HCV
infection group had a higher proportion of males than non-HCV
infection group (63% vs. 32%; P < 0.001).
After adjustment by multivariate logistic regression, the ﬁnal
model comprised of six factors (Table 2). Only three factorswere signiﬁcantly associated with HCV infection, namely male
gender, age, and family history of liver cancer. The adjusted ORs
and 95% CI of these factors were 3.14 (1.50, 6.56), 3.78 (1.12,
12.76), and 2.28 (1.08, 4.80), respectively.4. Discussion
The prevalence of HCV infection in this study was 5.21%,
which is higher than that in other reports and in the general pop-
ulation [6,7]. The estimated prevalence of HCV infection in the
published literature was 2.7% [6], while another report from
Thailand showed the prevalence of HCV infection to be 0.94%
[7]. The reason for low prevalence rate of the latter report was
that blood samples were collected primarily from pediatric health
checkups. The mean age of the participants was quite young,
resulting in a low rate of HCV infection. Further extensive
studies should be conducted to conﬁrm the national HCV
infection rate in Thailand. The high HCV infection rate in this
study may be due to two factors. First, participants in the survey
may be at higher-than-normal risk for HCV infection; second,
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they were at higher risk than younger people.
There are three independent factors associated with HCV
infection, including male gender, age, and family history of liver
cancer. These results suggested that males with a family history
of liver cancer in their ﬁrst-degree relatives should be tested for
HCV infection, regardless of symptoms. For every one-year in-
crease in age, risk of being found to be HCV positive increased
by 3.78 times. This recommendation may apply to endemic
countries for HCV infection, particularly developing countries [8].
There are two explanations for why men had a higher risk for
HCV infection than women. These are gender risk and HCV
clearance ability. HCV is primarily transmitted by through
blood, putting intravenous drug users, tattoo recipients, and men
who engage in sexual intercourse with other men particularly at
risk [9–11]. Men are at higher risk of contracting an infection in
these ways than are women. A report from Egypt [12] found that
females also had a higher ability to clear the HCV virus than
men (44.6% vs. 33.7%; P = 0.001). Increased age is also
associated with increased risk for HCV infection. A systematic
review found that three out of six articles indicated that age
was an independent factor for HCV infection [13]. A recent
study from China also found that the most common age group
was between 41 and 60 years and accounted for 60% of all
HCV infected patients [14].
A family history of liver cancer increases the risk for HCV
infection by 2.28 times. This ﬁnding may indicate that HCV may
be transmitted among family members, vertically or other routes.
Theoretically, the rate ofHCVvertical transmission ismuch lower
than HBV [15,16]. The transmission rate is 70%–90% for HBe
positive and 10%–40% for HBs positive HBV pregnant carriers
[15], while HCV transmission rate is 3%–10% [16]. HCV may
spread to spouse for ﬁve times in HCV group than non-HCV
group (OR = 5.75, 95% CI: 1.94–17.07) [14]. Parents with the
HCV gene have also been reported to pass HCV to their
children via sperm [17]. This evidence suggests that it is possible
that HCV may be vertically transmitted or transmitted among
family members and cause liver cancer in families. Those
people with a family history of liver cancer, HBV or HCV
should be tested. A study from China [14] also indicated that a
family history of HCV infection is associated with HCV
infection with adjusted odds ratio of 4.68 (95% CI of 2.67,
8.75). It may, therefore, be worthwhile to screen for HCV
infection in patients with a family history of HCV infection.
Other routes of transmission such as oral route as in
Campylobacter pylori require further investigation.
There are several limitations to this study. First, although it
included participants from almost every province in the north-
east Thailand, it may not be representative of the general pop-
ulation in the northeast or Thailand as a whole. Second, some
other factors are not included in the study such as the presence of
fatty liver disease, history of tattooing, or HCV genotypes. Body
mass index, smoking, and alcohol consumption were included in
the analysis, but they were not independent factors for HCV
infection in our results. Third, the results of this study may not
be universal particularly for areas that are not endemic for HBV
infection. Further studies are needed to conﬁrm the results of this
study both in endemic and non-endemic countries.
In conclusion, male gender, increasing age, and family his-
tory of liver cancer are predictors of HCV infection in endemic
areas. Males with a family history of liver cancer in their ﬁrst-
degree relatives should be tested for HCV infection regardlessof symptoms. Early HCV screening in younger age groups is
more beneﬁcial than HCV.
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